MA SONGJIANG (President) sold 0.1% of their position (4K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $43.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/14/2025ACC: 0001140361-25-018927
DirectorOfficer· President
Since Oct 2023
-4K
Net shares
Net seller
$43.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$10.56
Trade value
$21.12K
% of position
0.1%
5/12/2025
2.82M→2.82M
Common Stock
Indirect
Shares
−2K
Price / share
$11.37
Trade value
$22.74K
% of position
0.1%
5/13/2025
2.82M→2.82M
Total
Net shares
−4K
Net value
-$43.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/12/2025 | S · Sale | −2K | $10.56 | $21.12K | 0.1% | 2.82M | 2.82M |
| Common Stock Indirect | 5/13/2025 | S · Sale | −2K | $11.37 | $22.74K | 0.1% | 2.82M | 2.82M |
| Total | −4K | -$43.86K | ||||||
Derivative Transactions0
No derivative transactions reported